Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival

被引：34

作者：

van Besien, Koen ^{[1
,2
]}

Hari, Parameswaran ^{[3
]}

Zhang, Mei-Jie ^{[3
]}

Liu, Hong-Tao ^{[4
]}

Stock, Wendy ^{[4
]}

Godley, Lucy ^{[4
]}

Odenike, Olatoyosi ^{[4
]}

Larson, Richard ^{[4
]}

Bishop, Michael ^{[4
]}

Wickrema, Amittha ^{[4
]}

Gergis, Usama ^{[1
,2
]}

Mayer, Sebastian ^{[1
,2
]}

Shore, Tsiporah ^{[1
,2
]}

Tsai, Stephanie ^{[1
,2
]}

Rhodes, Joanna ^{[1
,2
]}

Cushing, Melissa M. ^{[5
]}

Korman, Sandra ^{[3
]}

Artz, Andrew ^{[1
,2
]}

机构：

[1] Weill Cornell Med Coll, Dept Hematol Oncol, New York, NY 10065 USA

[2] Weill Cornell Med Coll, Stem Cell Transplant Program, Meyer Canc Ctr, New York, NY 10065 USA

[3] Med Coll Wisconsin, Ctr Int Bone Marrow Transplant Res, Milwaukee, WI 53226 USA

[4] Univ Chicago, Sect Hematol Oncol, Hematopoiet Cellular Therapy Program, Chicago, IL 60637 USA

[5] Weill Cornell Med Coll, Cellular Therapy Lab, Dept Pathol, New York, NY USA

来源：

HAEMATOLOGICA | 2016年 / 101卷 / 05期

关键词：

HEMATOPOIETIC-CELL TRANSPLANTATION; ALTERNATIVE DONOR TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; BLOOD TRANSPLANTATION; ANTITHYMOCYTE GLOBULIN; UNRELATED DONOR; BONE-MARROW; MYELODYSPLASTIC SYNDROME; 3RD-PARTY DONOR; OLDER PATIENTS;

D O I：

10.3324/haematol.2015.138594

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Umbilical cord blood stem cell transplants are commonly used in adults lacking HLA-identical donors. Delays in hematopoietic recovery contribute to mortality and morbidity. To hasten recovery, we used co-infusion of progenitor cells from a partially matched related donor and from an umbilical cord blood graft (haplo-cord transplant). Here we compared the outcomes of haplo-cord and double-cord transplants. A total of 97 adults underwent reduced intensity conditioning followed by haplo-cord transplant and 193 patients received reduced intensity conditioning followed by double umbilical cord blood transplantation. Patients in the haplo-cord group were more often from minority groups and had more advanced malignancy. Haplo-cord recipients received fludarabine-melphalan-anti-thymocyte globulin. Double umbilical cord blood recipients received fludarabine-cyclophosphamide and low-dose total body irradiation. In a multivariate analysis, haplo-cord had faster neutrophil (HR=1.42, P=0.007) and platelet (HR=2.54, P<0.0001) recovery, lower risk of grade II-IV acute graft-versus-host disease (HR=0.26, P<0.0001) and chronic graft-versus-host disease (HR=0.06, P<0.0001). Haplo-cord was associated with decreased risk of relapse (HR 0.48, P=0.001). Graft-versus-host disease-free, relapse-free survival was superior with haplo-cord (HR 0.63, P=0.002) but not overall survival (HR=0.97, P=0.85). Haplo-cord transplantation using fludarabine-melphalan-thymoglobulin conditioning hastens hematopoietic recovery with a lower risk of relapse relative to double umbilical cord blood transplantation using the commonly used fludarabine-cyclophosphamide-low-dose total body irradiation conditioning. Graft-versus-host disease-free and relapse-free survival is significantly improved. Haplo-cord is a readily available graft source that improves outcomes and access to transplant for those lacking HLA-matched donors.

引用

页码：634 / 643

页数：10

共 50 条

[21] Factors Predicting Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center
Solh, Melhem
Zhang, Xu
Connor, Katelin
Brown, Stacey
Solomon, Scott R.
Morris, Lawrence E.
Holland, H. Kent
Bashey, Asad
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1403 - 1409
[22] Allogeneic transplantation for relapsed and refractory Hodgkin lymphoma: long-term outcomes and graft-versus-host disease-free/relapse-free survival
Spina, Francesco
Radice, Tommaso
De Philippis, Chiara
Soldarini, Martina
Di Chio, Maria Chiara
Dodero, Anna
Guidetti, Anna
Viviani, Simonetta
Corradini, Paolo
LEUKEMIA & LYMPHOMA, 2019, 60 (01) : 101 - 109
[23] Prognostic factors on graft-versus-host disease-free and relapse-free survival after allogeneic hematopoietic stem cell transplantation for adults with acute leukemia
Tan, Jie
Wang, Ya
Yu, Si-Jian
Ma, Yong-Yong
Lei, Hu-Yi
Liu, Qi-Fa
LEUKEMIA RESEARCH, 2017, 59 : 1 - 7
[24] Impact of the Difference in Body Mass Index at Transplantation from That at Diagnosis for Graft-Versus-Host Disease-Free, Relapse-Free Survival in Acute Myeloid Leukemia
Ando, Taiki
Yamazaki, Etsuko
Teshigawara, Haruka
Ogusa, Eriko
Ishii, Yoshimi
Miyashita, Kazuho
Motohashi, Kenji
Miyazaki, Takuya
Tachibana, Takayoshi
Hagihara, Maki
Matsumoto, Kenji
Tanaka, Masatsugu
Hashimoto, Chizuko
Koharazawa, Hideyuki
Fujimaki, Katsumichi
Taguchi, Jun
Fujita, Hiroyuki
Kanamori, Heiwa
Fujisawa, Shin
Nakajima, Hideaki
BLOOD, 2016, 128 (22)
[25] Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia
Giorgia Battipaglia
Annalisa Ruggeri
Myriam Labopin
Liisa Volin
Didier Blaise
Gerard Socié
Reza Tabrizi
Jan J. Cornelissen
Ardeshir Ghavamzadeh
Anne Huynh
Depei Wu
Ibrahim Yakoub-Agha
Johan Maertens
Patrice Chevallier
Mohamad Mohty
Arnon Nagler
Bone Marrow Transplantation, 2018, 53 : 1295 - 1303
[26] Refined graft-versus-host disease/relapse-free survival in transplant from HLA-identical related or unrelated donors in acute myeloid leukemia
Battipaglia, Giorgia
Ruggeri, Annalisa
Labopin, Myriam
Volin, Liisa
Blaise, Didier
Socie, Gerard
Tabrizi, Reza
Cornelissen, Jan J.
Ghavamzadeh, Ardeshir
Huynh, Anne
Wu, Depei
Yakoub-Agha, Ibrahim
Maertens, Johan
Chevallier, Patrice
Mohty, Mohamad
Nagler, Arnon
BONE MARROW TRANSPLANTATION, 2018, 53 (10) : 1295 - 1303
[27] A single-center analysis of chronic graft-versus-host disease-free, relapse-free survival after alternative donor stem cell transplantation in children with hematological malignancies
Inagaki, Jiro
Fukano, Reiji
Noguchi, Maiko
Okamura, Jun
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2017, 105 (05) : 676 - 685
[28] A single-center analysis of chronic graft-versus-host disease-free, relapse-free survival after alternative donor stem cell transplantation in children with hematological malignancies
Jiro Inagaki
Reiji Fukano
Maiko Noguchi
Jun Okamura
International Journal of Hematology, 2017, 105 : 676 - 685
[29] Graft-Versus-Host Disease (GVHD) Induced Graft-Versus-Leukemia (GVL) Effect: More Impact on Later Relapse and Disease-Free Survival Following Reduced Intensity Conditioning
Weisdorf, Daniel J.
Zhang, Mei-Jie
Arora, Mukta
Rizzo, J. Douglas
Horowitz, Mary M.
Eapen, Mary
BLOOD, 2011, 118 (21) : 464 - 465
[30] Graft-versus-host Disease-free, Relapse-free Survival After HLA-identical Sibling Peripheral Blood Stem Cell Transplantation With Tacrolimus-based Graft-versus-host Disease Prophylaxis in Japanese Patients
Shingaki, S.
Tsukada, N.
Ikeda, M.
Suzuki, K.
TRANSPLANTATION PROCEEDINGS, 2018, 50 (01) : 241 - 245

← 1 2 3 4 5 →